Price $209.51 |
Market Cap
31.68B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
55.0
|
P/B
8.02
|
P/S
14.52
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
39.9
|
Op. Cash Flow
805.4K
|
FCF
4.9
|
|
Op. Margin
18.10%
|
Net Margin
23.90%
|
ROE
14.50%
|
ROI
11.80%
|
|
ROA
11.50%
|
EPS Growth
23.50%
|
Current Ratio
3.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chromadex Corp (CDXC) | $1.42 | - | - | 117.7M | Strong Buy |
| Bimi International Medical Inc (BIMI) | $1.57 | - | - | 6.1M | Strong Buy |
| Baxter International Inc (BAX) | $38.96 | - | 2.50% | 23.05B | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $131.85 | - | - | 7.93B | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $1.60 | - | - | 6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
